Logo image of GDRX

GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GDRX - US38246G1085 - Common Stock

2.68 USD
-0.07 (-2.55%)
Last: 1/15/2026, 8:00:01 PM
2.69 USD
+0.01 (+0.37%)
After Hours: 1/15/2026, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GDRX. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX has an average financial health and profitability rating. GDRX is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, GDRX could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • GDRX had positive earnings in the past year.
  • GDRX had a positive operating cash flow in the past year.
  • GDRX had negative earnings in 4 of the past 5 years.
  • In the past 5 years GDRX always reported a positive cash flow from operatings.
GDRX Yearly Net Income VS EBIT VS OCF VS FCFGDRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • GDRX's Return On Assets of 2.40% is amongst the best of the industry. GDRX outperforms 85.71% of its industry peers.
  • GDRX's Return On Equity of 5.29% is amongst the best of the industry. GDRX outperforms 91.43% of its industry peers.
  • GDRX has a Return On Invested Capital of 5.73%. This is amongst the best in the industry. GDRX outperforms 82.86% of its industry peers.
Industry RankSector Rank
ROA 2.4%
ROE 5.29%
ROIC 5.73%
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
GDRX Yearly ROA, ROE, ROICGDRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • GDRX's Profit Margin of 3.97% is amongst the best of the industry. GDRX outperforms 88.57% of its industry peers.
  • GDRX's Profit Margin has declined in the last couple of years.
  • GDRX has a better Operating Margin (10.37%) than 85.71% of its industry peers.
  • GDRX's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 93.46%, GDRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • GDRX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.37%
PM (TTM) 3.97%
GM 93.46%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
GDRX Yearly Profit, Operating, Gross MarginsGDRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDRX is destroying value.
  • Compared to 1 year ago, GDRX has less shares outstanding
  • Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
  • Compared to 1 year ago, GDRX has an improved debt to assets ratio.
GDRX Yearly Shares OutstandingGDRX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GDRX Yearly Total Debt VS Total AssetsGDRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • GDRX has an Altman-Z score of 0.44. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
  • GDRX has a Altman-Z score (0.44) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of GDRX is 4.66, which is a neutral value as it means it would take GDRX, 4.66 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 4.66, GDRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.81 indicates that GDRX is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.81, GDRX is doing worse than 82.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 4.66
Altman-Z 0.44
ROIC/WACC0.55
WACC10.51%
GDRX Yearly LT Debt VS Equity VS FCFGDRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

  • GDRX has a Current Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
  • GDRX has a Current ratio of 3.11. This is in the better half of the industry: GDRX outperforms 62.86% of its industry peers.
  • GDRX has a Quick Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
  • GDRX's Quick ratio of 3.11 is fine compared to the rest of the industry. GDRX outperforms 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 3.11
GDRX Yearly Current Assets VS Current LiabilitesGDRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

  • GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.37%, which is quite good.
  • Measured over the past years, GDRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.47% on average per year.
  • Looking at the last year, GDRX shows a small growth in Revenue. The Revenue has grown by 1.30% in the last year.
  • Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%

3.2 Future

  • Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.32% on average per year.
  • Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GDRX Yearly Revenue VS EstimatesGDRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
GDRX Yearly EPS VS EstimatesGDRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.66 indicates a rather cheap valuation of GDRX.
  • Compared to the rest of the industry, the Price/Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 100.00% of the companies listed in the same industry.
  • GDRX is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 6.02, the valuation of GDRX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.66
Fwd PE 6.02
GDRX Price Earnings VS Forward Price EarningsGDRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 94.29% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, GDRX is valued cheaper than 91.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.67
EV/EBITDA 7
GDRX Per share dataGDRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GDRX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.77% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y16.13%
EPS Next 3Y16.77%

0

5. Dividend

5.1 Amount

  • GDRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GOODRX HOLDINGS INC-CLASS A

NASDAQ:GDRX (1/15/2026, 8:00:01 PM)

After market: 2.69 +0.01 (+0.37%)

2.68

-0.07 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04
Earnings (Next)02-25
Inst Owners50.75%
Inst Owner Change0.01%
Ins Owners11.19%
Ins Owner Change3.28%
Market Cap909.67M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts74.29
Price Target4.98 (85.82%)
Short Float %8.84%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-4.05%
PT rev (3m)-8.19%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)0.19%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.38%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 7.66
Fwd PE 6.02
P/S 1.14
P/FCF 8.67
P/OCF 5.06
P/B 1.51
P/tB N/A
EV/EBITDA 7
EPS(TTM)0.35
EY13.06%
EPS(NY)0.45
Fwd EY16.61%
FCF(TTM)0.31
FCFY11.53%
OCF(TTM)0.53
OCFY19.76%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.67
PEG (5Y)N/A
Graham Number3.73
Profitability
Industry RankSector Rank
ROA 2.4%
ROE 5.29%
ROCE 7.26%
ROIC 5.73%
ROICexc 7.53%
ROICexgc 26.92%
OM 10.37%
PM (TTM) 3.97%
GM 93.46%
FCFM 13.11%
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 4.66
Debt/EBITDA 2.95
Cap/Depr 92.2%
Cap/Sales 9.35%
Interest Coverage 250
Cash Conversion 109.5%
Profit Quality 330.43%
Current Ratio 3.11
Quick Ratio 3.11
Altman-Z 0.44
F-Score6
WACC10.51%
ROIC/WACC0.55
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y15.99%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%

GOODRX HOLDINGS INC-CLASS A / GDRX FAQ

Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?

ChartMill assigns a fundamental rating of 6 / 10 to GDRX.


What is the valuation status for GDRX stock?

ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.


What is the profitability of GDRX stock?

GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?

The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 11.45% in the next year.